ITMCTR2200005864
Not yet recruiting
Phase 1
Infectious Diseases
Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine0 sitesTBD
Conditionscovid-19
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- covid-19
- Sponsor
- Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Age 18\-65 years old (including 18 and 65 years old), regardless of gender;
- •(2\) Nucleic acid test results were positive, accompanied by fever, sore throat, cough and other mild clinical symptoms;
- •(3\) Voluntarily participate in the experiment and sign the written informed consent.
Exclusion Criteria
- •(1\) Complicated with influenza, other pneumonia, suppurative tonsillitis, acute tracheobronchial inflammation, pulmonary tuberculosis, primary ciliary dyskinesia syndrome, and other acute nasal diseases (such as allergic rhinitis, acute and chronic rhinitis, acute and chronic sinusitis, etc.);
- •(2\) During the course of the disease, he has received other oral drugs for the disease before treatment, such as cold drugs, antiviral drugs, antibiotics, traditional Chinese medicine and other drugs;
- •(3\) Accompanied by gastrointestinal discomfort symptoms such as acute and chronic diarrhea;
- •(4\) merge serious serious diseases such as heart, brain, lung, liver, kidney and blood system, such as viral hepatitis, hemophilia, diabetes mellitus, mental illness, etc.
- •(5\) Pregnant or planned pregnant women, lactating women, patients of childbearing age who are unable or unwilling to take adequate contraception during the trial, or their spouses are unwilling to take contraception;
- •(6\) Allergic constitution, such as a history of allergy to more than two drugs or foods, or known allergy to various components of the drug in this study;
- •(7\) Participate in or are participating in clinical trials of other drugs within 3 months;
- •(8\) According to the judgment of the researcher, there are other diseases or conditions that reduce the possibility of enrollment or complicate enrollment, such as frequent changes in working environment, unstable living environment and other conditions that are easy to cause loss of follow\-up.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
A prospective covid-19 cohort study of Jingyin granule in the treatment of mild and asymptomatic infections in patients with new crown pneumoniacovid-19ITMCTR2200005862Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Not yet recruiting
Phase 1
A prospective covid-19 cohort study of Zheng Qi tablet in the treatment of mild and asymptomatic infections in patients with new crown pneumoniacovid-19ITMCTR2200005863Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Not yet recruiting
Not Applicable
A randomized, double-blind, low dose controlled clinical trial of Jingyin granule in the treatment of asymptomatic infection in covid-19.ITMCTR2200005865Shuguang Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Not yet recruiting
Not Applicable
Prevalence of common bacterial infections causing abnormal vaginal discharge1. 18 years old or above Thai female.2. History of sexual intercourse within 1 year.3. Present with LeukorrheaLeukorrhea, thai female, white blood cell number, cervicitis, chlamydial infection, wet smear, gram stain, PCR, abnormal vaginal dischargeTCTR20210702001Faculty of Medicine, Siriraj Hospital150
Recruiting
Phase 1
Coadministration of Malignancy and Infection specific T cells after allogeneic stem cell Transplant for Acute Leukaemia with CD34+ selected stem cellsACTRN12618001090202Western Sydney Local Health District, Westmead Hospital20